首頁 > 市場調查報告書 > 醫療設備

眼科設備

人工角膜和角膜植入市場規模、佔有率和成長分析（按類型、植入物類型、疾病適應症、最終用戶和地區分類）—產業預測，2026-2033年

市場調查報告書

商品編碼

1896046

人工角膜和角膜植入市場規模、佔有率和成長分析（按類型、植入物類型、疾病適應症、最終用戶和地區分類）—產業預測，2026-2033年

Artificial Cornea and Corneal Implant Market Size, Share, and Growth Analysis, By Type (Human Cornea, Artificial Cornea), By Transplant Type, By Disease Indication, By End User, By Region - Industry Forecast 2026-2033

出版日期: 2025年12月15日 | 出版商:

SkyQuest | 英文 219 Pages | 商品交期: 3-5個工作天內

價格

簡介目錄

全球人工角膜和角膜植入市場規模預計在 2024 年達到 4.8781 億美元，從 2025 年的 5.2391 億美元成長到 2033 年的 9.2745 億美元，在預測期（2026-2033 年）內複合年成長率為 7.4%。

市場分析表明，眼疾發病率的上升以及消費者對眼科保健投入意願的增強，預計將推動人工角膜和角膜植入的需求成長。此外，人們對眼角膜捐贈意識的提高以及器官捐贈者數量的增加也是促進市場成長的因素。可靠的眼移植手術的日益普及以及相關醫療報銷的改善，進一步支撐了人工角膜和角膜植入的銷售成長。然而，某些地區的高成本可能會限制市場發展。此外，全球人口老化的快速成長將持續推動對人工角膜和角膜植入的需求，使其成為不斷發展的眼科保健領域的重要組成部分。

推動全球人工角膜和角膜植入市場發展的因素

全球人口老化以及螢幕使用時間的增加，顯著加劇了角膜疾病的盛行率。眼部疾病的激增推動了角膜移植作為治療選擇的需求成長。因此，人工角膜和角膜植入的需求預計將會成長，這反映出眼科領域對創新解決方案的迫切需求。隨著越來越多的患者面臨角膜健康問題，人工角膜和植入市場有望從中受益，使其成為應對不斷變化的人口健康需求的關鍵解決方案。

限制全球人工角膜和角膜植入市場發展的因素

全球人工角膜和角膜植入市場面臨許多挑戰，主要原因是各種醫療保險計劃對角膜移植手術的覆蓋範圍和報銷額度有限。因此，許多患者不得不自費承擔這些費用。高昂的手術費用可能會阻礙患者進行如此大額的投資，從而抑制市場的整體成長和擴張。由此，患者面臨的經濟負擔成為一大阻礙因素，限制了他們獲得必要的治療，並阻礙了創新型角膜解決方案的研發。

全球人工角膜和角膜植入市場趨勢

全球人工角膜和角膜植入市場正呈現出微創手術技術日益普及的顯著趨勢。隨著患者偏好轉向這些創傷較小的治療方案，製造商正致力於提升此類手術產品的可及性和有效性。同時，為這些先進療法爭取有利的報銷機制預計將進一步推動市場需求和擴張。這種不斷變化的市場格局不僅凸顯了創新解決方案的重要性，也強烈提醒市場相關人員，必須適應眼科護理領域消費者不斷變化的需求。

北美洲
- 美國
- 加拿大
歐洲
- 德國
- 西班牙
- 法國
- 英國
- 義大利
- 其他歐洲地區
亞太地區
- 中國
- 印度
- 日本
- 韓國
- 亞太其他地區
拉丁美洲
- 巴西
- 其他拉丁美洲地區
中東和非洲
- 海灣合作理事會國家
- 南非
- 其他中東和非洲地區

競爭資訊

前五大公司對比
主要企業的市場定位（2025 年）
主要市場參與者所採取的策略
近期市場趨勢
公司市佔率分析（2025 年）
主要企業公司簡介
- 公司詳情
- 產品系列分析
- 依業務板塊進行公司股票分析
- 2023-2025年營收年比比較

主要企業簡介

CorNeat Vision（Israel）
KeraMed, Inc.（USA）
LinkoCare Life Sciences AB（Sweden）
DIOPTEX GmbH（Austria）
EyeYon Medical（Israel）
AJL Ophthalmic SA（Spain）
Mediphacos（Brazil）
CorneaGen（USA）
Florida Lions Eye Bank（USA）
San Diego Eye Bank（USA）
Alabama Eye Bank（USA）
Massachusetts Eye and Ear（USA）
Advancing Sight Network（USA）
LV Prasad Eye Institute（LVPEI, India）
Alcon Inc.（Switzerland）
Aurolab（India）
Cornea Biosciences（USA）
Price Vision Group（USA）

結論與建議

簡介目錄

Product Code: SQMIG35B2204

Global Artificial Cornea and Corneal Implant Market size was valued at USD 487.81 Million in 2024 and is poised to grow from USD 523.91 Million in 2025 to USD 927.45 Million by 2033, growing at a CAGR of 7.4% during the forecast period (2026-2033).

Market insights reveal that the rising incidence of ophthalmic diseases, combined with consumers' increased willingness to invest in eye care, is expected to enhance demand for artificial corneas and corneal implants. Additionally, heightened awareness about eye donation and a growing number of organ donors are contributing factors to the expansion of this market. The growing accessibility of reliable eye transplant procedures and improvements in reimbursement for these procedures further support the anticipated sales growth of artificial corneas and corneal implants. Nonetheless, high costs in certain regions may impede market development. Furthermore, the rapidly increasing geriatric population globally is likely to drive sustained demand for artificial corneas and corneal implants, positioning them as critical components in the evolving eye care landscape.

Top-down and bottom-up approaches were used to estimate and validate the size of the Global Artificial Cornea and Corneal Implant market and to estimate the size of various other dependent submarkets. The research methodology used to estimate the market size includes the following details: The key players in the market were identified through secondary research, and their market shares in the respective regions were determined through primary and secondary research. This entire procedure includes the study of the annual and financial reports of the top market players and extensive interviews for key insights from industry leaders such as CEOs, VPs, directors, and marketing executives. All percentage shares split, and breakdowns were determined using secondary sources and verified through Primary sources. All possible parameters that affect the markets covered in this research study have been accounted for, viewed in extensive detail, verified through primary research, and analyzed to get the final quantitative and qualitative data.

Global Artificial Cornea and Corneal Implant Market Segments Analysis

Global Artificial Cornea and Corneal Implant Market is segmented by Type, Transplant Type, Disease Indication, End User and region. Based on Type, the market is segmented into Human Cornea and Artificial Cornea. Based on Transplant Type, the market is segmented into Penetrating Keratoplasty, Endothelial Keratoplasty, Anterior lamellar keratoplasty and keratoprosthesis. Based on Disease Indication, the market is segmented into Fuchs' Dystrophy, Fungal Keratitis, Keratoconus and Others. Based on End User, the market is segmented into Hospitals & Ambulatory Surgical Centers and Specialty Clinics. Based on region, the market is segmented into North America, Europe, Asia Pacific, Latin America and Middle East & Africa.

Driver of the Global Artificial Cornea and Corneal Implant Market

The rising global aging population, coupled with heightened exposure to screens, has significantly contributed to the prevalence of corneal disorders. This surge in eye-related issues is driving an increasing demand for corneal transplantation as a treatment option. As a result, the need for artificial corneas and corneal implants is expected to grow, reflecting the urgent requirement for innovative solutions in eye care. With more individuals facing corneal health challenges, the market for artificial corneas and implants stands to benefit, showcasing a critical response to the health needs of an evolving demographic landscape.

Restraints in the Global Artificial Cornea and Corneal Implant Market

The Global Artificial Cornea and Corneal Implant market faces challenges due to limited coverage and reimbursement for corneal transplantation procedures by various healthcare insurance plans. As a result, many individuals must finance these services out of their own pockets. The high costs associated with these procedures contribute to patients' reluctance to invest significant amounts of money, which may hinder the overall growth and expansion of the market. Consequently, the financial burden placed on patients can act as a significant restraint, limiting access to essential treatments and impeding the advancement of innovative corneal solutions.

Market Trends of the Global Artificial Cornea and Corneal Implant Market

The global market for artificial corneas and corneal implants is witnessing a significant trend towards the adoption of minimally invasive surgical techniques. As patient preferences shift towards these less invasive options, manufacturers are encouraged to enhance the accessibility and efficacy of their products tailored for such procedures. Concurrently, a focus on securing favorable reimbursement frameworks for these advanced treatments is expected to further stimulate demand and expansion within the market. This evolving landscape not only highlights the importance of innovative solutions but also underscores the necessity for market players to adapt to evolving consumer expectations in ocular health.

Introduction

Objectives of the Study
Scope of the Report
Definitions

Research Methodology

Information Procurement
Secondary & Primary Data Methods
Market Size Estimation
Market Assumptions & Limitations

Executive Summary

Global Market Outlook
Supply & Demand Trend Analysis
Segmental Opportunity Analysis

Market Dynamics & Outlook

Market Overview
Market Size
Market Dynamics
- Drivers & Opportunities
- Restraints & Challenges
Porters Analysis
- Competitive rivalry
- Threat of substitute
- Bargaining power of buyers
- Threat of new entrants
- Bargaining power of suppliers

Key Market Insights

Key Success Factors
Degree of Competition
Top Investment Pockets
Market Ecosystem
Market Attractiveness Index, 2025
PESTEL Analysis
Macro-Economic Indicators
Value Chain Analysis
Pricing Analysis

Global Artificial Cornea and Corneal Implant Market Size by Type & CAGR (2026-2033)

Market Overview
Human Cornea
Artificial Cornea

Global Artificial Cornea and Corneal Implant Market Size by Transplant Type & CAGR (2026-2033)

Market Overview
Penetrating Keratoplasty
Endothelial Keratoplasty
Anterior lamellar keratoplasty
keratoprosthesis

Global Artificial Cornea and Corneal Implant Market Size by Disease Indication & CAGR (2026-2033)

Market Overview
Fuchs' Dystrophy
Fungal Keratitis
Keratoconus
Others

Global Artificial Cornea and Corneal Implant Market Size by End User & CAGR (2026-2033)

Market Overview
Hospitals & Ambulatory Surgical Centers
Specialty Clinics

Global Artificial Cornea and Corneal Implant Market Size & CAGR (2026-2033)

North America (Type, Transplant Type, Disease Indication, End User)
- US
- Canada
Europe (Type, Transplant Type, Disease Indication, End User)
- Germany
- Spain
- France
- UK
- Italy
- Rest of Europe
Asia Pacific (Type, Transplant Type, Disease Indication, End User)
- China
- India
- Japan
- South Korea
- Rest of Asia-Pacific
Latin America (Type, Transplant Type, Disease Indication, End User)
- Brazil
- Rest of Latin America
Middle East & Africa (Type, Transplant Type, Disease Indication, End User)
- GCC Countries
- South Africa
- Rest of Middle East & Africa

Competitive Intelligence

Top 5 Player Comparison
Market Positioning of Key Players, 2025
Strategies Adopted by Key Market Players
Recent Developments in the Market
Company Market Share Analysis, 2025
Company Profiles of All Key Players
- Company Details
- Product Portfolio Analysis
- Company's Segmental Share Analysis
- Revenue Y-O-Y Comparison (2023-2025)

Key Company Profiles

CorNeat Vision (Israel)
- Company Overview
- Business Segment Overview
- Financial Updates
- Key Developments
KeraMed, Inc. (USA)
- Company Overview
- Business Segment Overview
- Financial Updates
- Key Developments
LinkoCare Life Sciences AB (Sweden)
- Company Overview
- Business Segment Overview
- Financial Updates
- Key Developments
DIOPTEX GmbH (Austria)
- Company Overview
- Business Segment Overview
- Financial Updates
- Key Developments
EyeYon Medical (Israel)
- Company Overview
- Business Segment Overview
- Financial Updates
- Key Developments
AJL Ophthalmic SA (Spain)
- Company Overview
- Business Segment Overview
- Financial Updates
- Key Developments
Mediphacos (Brazil)
- Company Overview
- Business Segment Overview
- Financial Updates
- Key Developments
CorneaGen (USA)
- Company Overview
- Business Segment Overview
- Financial Updates
- Key Developments
Florida Lions Eye Bank (USA)
- Company Overview
- Business Segment Overview
- Financial Updates
- Key Developments
San Diego Eye Bank (USA)
- Company Overview
- Business Segment Overview
- Financial Updates
- Key Developments
Alabama Eye Bank (USA)
- Company Overview
- Business Segment Overview
- Financial Updates
- Key Developments
Massachusetts Eye and Ear (USA)
- Company Overview
- Business Segment Overview
- Financial Updates
- Key Developments
Advancing Sight Network (USA)
- Company Overview
- Business Segment Overview
- Financial Updates
- Key Developments
L V Prasad Eye Institute (LVPEI, India)
- Company Overview
- Business Segment Overview
- Financial Updates
- Key Developments
Alcon Inc. (Switzerland)
- Company Overview
- Business Segment Overview
- Financial Updates
- Key Developments
Aurolab (India)
- Company Overview
- Business Segment Overview
- Financial Updates
- Key Developments
Cornea Biosciences (USA)
- Company Overview
- Business Segment Overview
- Financial Updates
- Key Developments
Price Vision Group (USA)
- Company Overview
- Business Segment Overview
- Financial Updates
- Key Developments